Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation.

G protein-coupled receptors induce EGF receptor (EGFR) signaling, leading to the proliferation and invasion of cancer cells. Elucidation of the mechanism of EGFR activation by G protein-coupled receptors may identify new signaling paradigms. A gastrin-releasing peptide (GRP)/GRP receptor-mediated autocrine pathway was previously described in squamous cell carcinoma of head and neck. In the present study, we demonstrate that TNF-alpha converting enzyme (TACE), a disintegrin and metalloproteinse-17, undergoes a Src-dependent phosphorylation that regulates release of the EGFR ligand amphiregulin upon GRP treatment. Further investigation reveals the phosphatidylinositol 3-kinase (PI3-K) as the intermediate of c-Src and TACE, contributing to their association and TACE phosphorylation. Phosphoinositide-dependent kinase 1 (PDK1), a downstream target of PI3-K, has been identified as the previously undescribed kinase to directly phosphorylate TACE upon GRP treatment. These findings suggest a signaling cascade of GRP-Src-PI3-K-PDK1-TACE-amphiregulin-EGFR with multiple points of interaction, translocation, and phosphorylation. Furthermore, knockdown of PDK1 augmented the antitumor effects of the EGFR inhibitor erlotinib, indicating PDK1 as a therapeutic target to improve the clinical response to EGFR inhibitors.

[1]  Shunqiang Li,et al.  Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach , 2005, Nature Medicine.

[2]  S. Ghosh,et al.  PDK1 Nucleates T Cell Receptor-Induced Signaling Complex for NF-κB Activation , 2005, Science.

[3]  J. Siegfried,et al.  Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells. , 2005, Neoplasia.

[4]  A. Ullrich,et al.  Distinct ADAM Metalloproteinases Regulate G Protein-coupled Receptor-induced Cell Proliferation and Survival* , 2004, Journal of Biological Chemistry.

[5]  J. Siegfried,et al.  Src Family Kinases Mediate Epidermal Growth Factor Receptor Ligand Cleavage, Proliferation, and Invasion of Head and Neck Cancer Cells , 2004, Cancer Research.

[6]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[7]  Carlos L Arteaga,et al.  Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them? , 2004, Cancer cell.

[8]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[9]  Ricardo M Biondi,et al.  Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation. , 2004, Trends in biochemical sciences.

[10]  A. Ullrich,et al.  Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion , 2004, Oncogene.

[11]  T. Gudermann,et al.  Matrix Metalloproteinases 2 and 9 Mediate Epidermal Growth Factor Receptor Transactivation by Gonadotropin-releasing Hormone* , 2003, Journal of Biological Chemistry.

[12]  R. Auger,et al.  Regulated Cell Surface Pro-EGF Ectodomain Shedding Is a Zinc Metalloprotease-dependent Process* , 2003, Journal of Biological Chemistry.

[13]  Yiling Lu,et al.  Src Family Protein-tyrosine Kinases Alter the Function of PTEN to Regulate Phosphatidylinositol 3-Kinase/AKT Cascades* , 2003, Journal of Biological Chemistry.

[14]  J. Siegfried,et al.  Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor , 2003, Oncogene.

[15]  M. Gallup,et al.  Tobacco Smoke-induced Lung Cell Proliferation Mediated by Tumor Necrosis Factor α-converting Enzyme and Amphiregulin* , 2003, Journal of Biological Chemistry.

[16]  B. H. Shah,et al.  Roles of Src and Epidermal Growth Factor Receptor Transactivation in Transient and Sustained ERK1/2 Responses to Gonadotropin-releasing Hormone Receptor Activation* , 2003, Journal of Biological Chemistry.

[17]  R. Derynck,et al.  Characterization of Growth Factor-induced Serine Phosphorylation of Tumor Necrosis Factor-α Converting Enzyme and of an Alternatively Translated Polypeptide* , 2003, The Journal of Biological Chemistry.

[18]  Stefan Hart,et al.  TACE cleavage of proamphiregulin regulates GPCR‐induced proliferation and motility of cancer cells , 2003, The EMBO journal.

[19]  Ricardo M Biondi,et al.  Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. , 2003, The Biochemical journal.

[20]  A. Senderowicz.  Novel Small Molecule Cyclin-Dependent Kinases Modulators in Human Clinical Trials , 2003, Cancer biology & therapy.

[21]  T. Harris.  PDK1 and PKB/Akt: Ideal Targets for Development of New Strategies to Structure‐Based Drug Design , 2003, IUBMB life.

[22]  E. Levin,et al.  Proximal Events in Signaling by Plasma Membrane Estrogen Receptors* , 2003, The Journal of Biological Chemistry.

[23]  R. Coffey,et al.  Transactivation of the Epidermal Growth Factor Receptor in Colonic Epithelial Cells by Carbachol Requires Extracellular Release of Transforming Growth Factor-α* , 2002, The Journal of Biological Chemistry.

[24]  Z. Werb,et al.  The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein–coupled receptors , 2002, The Journal of cell biology.

[25]  E. Dı́az-Rodrı́guez,et al.  Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. , 2002, Molecular biology of the cell.

[26]  T. Tsuruo,et al.  Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine) , 2002, Oncogene.

[27]  J. Siegfried,et al.  Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck. , 2002, Journal of the National Cancer Institute.

[28]  A. Tarnawski,et al.  Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy , 2002, Nature Medicine.

[29]  M. Houslay,et al.  Phosphorylation-dependent Interactions between ADAM15 Cytoplasmic Domain and Src Family Protein-tyrosine Kinases* , 2002, The Journal of Biological Chemistry.

[30]  G. Mills,et al.  Tyrosine Phosphorylation of p85 Relieves Its Inhibitory Activity on Phosphatidylinositol 3-Kinase* , 2001, The Journal of Biological Chemistry.

[31]  M. Andjelkovic,et al.  Insulin-stimulated Protein Kinase B Phosphorylation on Ser-473 Is Independent of Its Activity and Occurs through a Staurosporine-insensitive Kinase* , 2001, The Journal of Biological Chemistry.

[32]  A. Ullrich,et al.  Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission , 2001, Oncogene.

[33]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[34]  D. Stokoe,et al.  Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival , 2000, Current Biology.

[35]  K. Garber.  Tyrosine kinase inhibitor research presses on despite halted clinical trial. , 2000, Journal of the National Cancer Institute.

[36]  R. Black,et al.  Functional Analysis of the Domain Structure of Tumor Necrosis Factor-α Converting Enzyme* , 2000, The Journal of Biological Chemistry.

[37]  B. Vanhaesebroeck,et al.  The PI3K-PDK1 connection: more than just a road to PKB. , 2000, The Biochemical journal.

[38]  J. Baselga.  Therapeutic monoclonal antibodies in oncology: an update: Monoclonal antibodies directed at growth factor receptors , 2000 .

[39]  P. Cohen,et al.  Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. , 1999, The Biochemical journal.

[40]  Phillip T. Hawkins,et al.  Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B , 1998, Current Biology.

[41]  M. Andjelkovic,et al.  Phosphorylation and activation of p70s6k by PDK1. , 1998, Science.

[42]  A. Ullrich,et al.  Signal characteristics of G protein‐transactivated EGF receptor , 1997, The EMBO journal.

[43]  A. Ullrich,et al.  Critical Role of Calcium- dependent Epidermal Growth Factor Receptor Transactivation in PC12 Cell Membrane Depolarization and Bradykinin Signaling* , 1997, The Journal of Biological Chemistry.

[44]  Colin B. Reese,et al.  3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase , 1997, Current Biology.

[45]  F. McCormick,et al.  Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. , 1997, Science.

[46]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[47]  P. Crespo,et al.  Linkage of G Protein-Coupled Receptors to the MAPK Signaling Pathway Through PI 3-Kinase γ , 1997, Science.

[48]  Robert J. Lefkowitz,et al.  Role of c-Src Tyrosine Kinase in G Protein-coupled Receptorand Gβγ Subunit-mediated Activation of Mitogen-activated Protein Kinases* , 1996, The Journal of Biological Chemistry.

[49]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[50]  R. Lefkowitz,et al.  G protein beta gamma subunits stimulate phosphorylation of Shc adapter protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. Lefkowitz,et al.  Distinct Pathways of G- and G-mediated Mitogen-activated Protein Kinase Activation (*) , 1995, The Journal of Biological Chemistry.

[52]  S. Schreiber,et al.  Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. , 1995, Science.

[53]  J. Cambier,et al.  Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit. , 1994, Science.

[54]  V. Dixit,et al.  Monocyte killing of human squamous epithelial cells: role for thrombospondin. , 1989, Cancer research.

[55]  C. Snyderman,et al.  Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. , 1989, Cancer research.

[56]  S. Pathak,et al.  Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. , 1988, Cancer research.